Controls | 30 | 2.3 (2.9) | 9.8 (5.5) | 5024.5 (2184.5) | 1.7 (0.6) |
JIA - whole group | 44 | 6.5 (7.4) | 12.1 (7.3) | 5761.3 (2856.1) | 1.9 (1.3) |
Type of onset |
Oligoarthritis | 10 | 3.7 (3.9) | 11.2 (9.4) | 6308.0 (3512.1) | 1.0 (0.4) |
Polyarthritis | 24 | 4.8 (7.1) | 13.1 (7.2) | 5661.0 (2427.2) | 1.1 (0.6) |
Systemic | 10 | 13.5 (7.1) | 9.7 (3.8) | 5502.9 (3557.6) | 3.6 (2.1) |
Activity of the disease |
Low | 11 | 2.7 (2.5) | 13.2 (13.2) | 6894.0 (2736.1) | 1.6 (0.1) |
Moderate | 15 | 4.9 (8.1) | 10.9 (6.9) | 5492.5 (2345.1) | 1.8 (1.4) |
High | 18 | 9.2 (8.0) | 12.6 (5.5) | 5455.0 (3196.0) | 2.3 (1.6) |
Statistics (p values) |
Control v JIA | | 0.020* | 0.331 | 0.424 | 0.825 |
Control v oligoarthritis | | 0.381 | 0.859 | 0.351 | 0.046* |
Control v polyarthritis | | 0.123 | 0.206 | 0.411 | 0.950 |
Control v systemic disease | | 0.001* | 0.780 | 0.867 | 0.012* |
Control v low activity | | 0.437 | 0.938 | 0.071 | 0.612 |
Control v moderate activity | | 0.517 | 0.596 | 0.496 | 0.517 |
Control v high activity | | 0.001* | 0.195 | 0.878 | 0.203 |
Acute phase indicators | | v TdT | v CD95 | v sFAS | v IL15 |
Lymphocyte count | | 0.098, rs=0.313 | 0.368, rs=−0.196 | 0.038*, rs=−0.313 | 0.867, rs=−0.035 |
Platelet count | | 0.495, rs=−0.137 | 0.068, rs=0.404 | 0.438, rs=−0.122 | 0.543, rs=−0.133 |
CRP | | 0.017*, rs=0.460 | 0.469, rs=−0.166 | 0.172, rs=−0.225 | 0.039*, rs=0.442 |
ESR | | 0.005*, rs=0.502 | 0.867, rs=0.036 | 0.114, rs=−0.241 | 0.089, rs=0.347 |